Condition (MeSH)
Rickettsia Infections
ClinicalTrials.gov lists 13 trials for Rickettsia Infections or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
8 of the 13 trials are tagged with Rickettsia Infections itself; the rest are tagged with a narrower condition beneath it.
When did Rickettsia Infections trials start? (12)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 2/3
- Phase 3
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2024 | 1 |
| 2023 | 1 |
| 2022 | 2 |
| 2020 | 1 |
| 2019 | 1 |
| 2014 | 1 |
| 2013 | 1 |
| 2009 | 1 |
Showing 10 of 12 earlier years.
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Rickettsia Infections trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 2/3 | 1 |
| Phase 3 | 1 |
| Not applicable | 3 |
| Observational | 7 |
How many Rickettsia Infections trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Completed | 6 |
| Unknown status | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Interventions as named in the registry (4)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| 1% Azithromycin | 1 |
| Azithromycin + Doxycycline | 1 |
| memantine ER | 1 |
| Doxycline | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Rickettsia Infections? (20)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Tick-borne lymphadenopathy in northeastern France: a human and vector clinical-epidemiological study. | Parasites & vectors | 2025 | Yes |
| Etiological spectrum of persistent fever in the tropics and predictors of ubiquitous infections: a prospective four-country study with pooled analysis. | BMC medicine | 2022 | Yes |
| Seroprevalence of Scrub Typhus, Typhus, and Spotted Fever Among Rural and Urban Populations of Northern Vietnam. | The American journal of tropical medicine and hygiene | 2017 | Yes |
| Seroprevalence of rickettsial infections and Q fever in Bhutan. | PLoS neglected tropical diseases | 2017 | Yes |
| Seroepidemiology of rickettsial infections in Northeast India. | Transactions of the Royal Society of Tropical Medicine and Hygiene | 2016 | Yes |
Showing 5 of 20 publications.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Rickettsial disease | 102021 | Exact | Orphadata Science knowledge files, Product 1 |
| Rickettsial disease | 102021 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and prevalence.